2026 NPPES data Glaucoma Specialist (Ophthalmology) Physician NPI 1235423260 MD
Verify on CMS →

DAVID SOLA-DEL VALLE, MD

Glaucoma Specialist (Ophthalmology) Physician in BOSTON, Massachusetts. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
6K
Medicare Part D claims · 746 beneficiaries · Glaucoma Specialist (Ophthalmology) Physician avg: 3K
Industry payments
$27.0K
43 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: DAVID SOLA-DEL VALLE, MD is a Glaucoma Specialist (Ophthalmology) Physician ([object Object]) practicing in BOSTON, Massachusetts with a Medicare Part D prescribing footprint of 6K claims across 746 beneficiaries . Industry payments of $27.0K across 43 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: DAVID SOLA-DEL VALLE, MD filed 5,935 Medicare Part D claims in 2023 across BOSTON, Massachusetts. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board-eligible specialty (heuristic — not verified)

DAVID SOLA-DEL VALLE, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

DAVID SOLA-DEL VALLE, MD at a glance

Quality data not reported

NPI registry status

Active

Issued 06/07/2011

NPI 1235423260

Primary specialty

Glaucoma Specialist (Ophthalmology) Physician

Rare

354 US NPIs in this specialty

Medicare Part D claims

5,935 100% vs specialty avg

2023 prescription claims

Specialty avg: 2,962

Specialty distribution in Massachusetts

How Glaucoma Specialist (Ophthalmology) Physician compares to other specialties among Massachusetts providers

Massachusetts providers

Glaucoma Specialist (Ophthalmology) Physician share within Massachusetts

1. Glaucoma Specialist (Ophthalmology) Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Glaucoma Specialist (Ophthalmology) Physician share within Massachusetts

Specialty board-certification context

Estimated specialty board-certified rate — Glaucoma Specialist (Ophthalmology) Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Glaucoma Specialist (Ophthalmology) Physician ABMS/AOA estimate

Est. board-certified rate (Glaucoma Specialist (Ophthalmology) Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Glaucoma Specialist (Ophthalmology) Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

DAVID SOLA-DEL VALLE, MD is a Glaucoma Specialist (Ophthalmology) Physician provider practicing in BOSTON, Massachusetts, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1235423260. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

DAVID SOLA-DEL VALLE, MD appears in the CMS NPPES registry as a Glaucoma Specialist (Ophthalmology) Physician provider holding MD credentials at 319 A ST UNIT 208, BOSTON, MA, 02210, with a listed phone of (787) 340-3379. NPI 1235423260 was issued on 06/07/2011. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what SOLA-DEL VALLE most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 5,935 prescription claims written by this provider, covering 746 Medicare beneficiaries and totaling roughly $1.4 million in drug spend. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Glaucoma Specialist (Ophthalmology) Physician is a narrow specialty nationwide, with 354 enrolled providers across 42 states and an average of 2,962 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

319 A ST UNIT 208
BOSTON, MA 02210

Provider Details

NPI 1235423260
Specialty Glaucoma Specialist (Ophthalmology) Physician
Credentials MD
Gender Male
NPI Issued 06/07/2011

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for DAVID SOLA-DEL VALLE, MD. Source: openpaymentsdata.cms.gov.

Total received

$27.0K

Largest payer

Thea Pharma Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Massachusetts BORIM 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~38K Massachusetts medical licensees in 2023 — they are NOT specific to DAVID SOLA-DEL VALLE, MD. To verify DAVID SOLA-DEL VALLE, MD's current license status, search the BORIM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

80
Total board actions, Massachusetts 2023
Across 78 cases
2.11
Actions per 1,000 licensees
Massachusetts statewide rate
probation
Most common action type
29 cases

BORIM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Massachusetts disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

5,935
Total Claims
$1.4M
Total Drug Cost
746
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
12,439
Total Day Supply
361,444
Generic Drug Cost
$291K
Antibiotic Claims
22

Patient Demographics

Average Patient Age
75.1 years
Avg HCC Risk Score
1.29
Gender Split
58% female / 42% male
Age Distribution
<65: 59, 65-74: 293, 75-84: 289, 85+: 105

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Latanoprost
902
Brimonidine Tartrate
650
Dorzolamide-Timolol
Dorzolamide Hcl/Timolol Maleat
530
Rhopressa
Netarsudil Mesylate
485
Prednisolone Acetate
369
Vyzulta
Latanoprostene Bunod
282
Timolol Maleate
280
Dorzolamide Hcl
205
Alphagan P
Brimonidine Tartrate
174

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Glaucoma Specialist (Ophthalmology) Physician Overview

How DAVID SOLA-DEL VALLE, MD fits within the Glaucoma Specialist (Ophthalmology) Physician landscape nationally.

354
Glaucoma Specialist (Ophthalmology) Physician Providers in US
42
States with Glaucoma Specialist (Ophthalmology) Physician
2,962
Avg Claims per Provider

DAVID SOLA-DEL VALLE, MD's 5,935 claims are above the specialty average of 2,962.

Nearby Glaucoma Specialist (Ophthalmology) Physician Providers in Massachusetts

Other clinicians with the same primary specialty enrolled in Massachusetts, drawn from the same CMS NPPES roster as SOLA-DEL VALLE.

Compare Glaucoma Specialist (Ophthalmology) Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is DAVID SOLA-DEL VALLE, MD's specialty?
DAVID SOLA-DEL VALLE, MD specializes in Glaucoma Specialist (Ophthalmology) Physician and practices in BOSTON, Massachusetts. Credentials: MD.
How much does DAVID SOLA-DEL VALLE, MD prescribe under Medicare Part D?
In 2023, DAVID SOLA-DEL VALLE, MD wrote 5,935 Medicare Part D claims totaling $1.4M in drug costs for 746 beneficiaries.
Where is DAVID SOLA-DEL VALLE, MD located?
DAVID SOLA-DEL VALLE, MD is located at 319 A ST UNIT 208, BOSTON, MA, 02210. Phone: (787) 340-3379.
What is DAVID SOLA-DEL VALLE, MD's NPI number?
DAVID SOLA-DEL VALLE, MD's National Provider Identifier (NPI) is 1235423260, issued on 06/07/2011.
How many Glaucoma Specialist (Ophthalmology) Physician providers are there in the US?
There are 354 Glaucoma Specialist (Ophthalmology) Physician providers across 42 states in the US. The average Glaucoma Specialist (Ophthalmology) Physician provider writes 2,962 Medicare Part D claims per year.
What drugs does DAVID SOLA-DEL VALLE, MD prescribe most often?
Based on 2023 Medicare Part D data, DAVID SOLA-DEL VALLE, MD's most frequently prescribed drugs include Latanoprost, Brimonidine Tartrate, Dorzolamide-Timolol. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does DAVID SOLA-DEL VALLE, MD accept Medicare?
DAVID SOLA-DEL VALLE, MD appears in CMS Medicare data with 5,935 Part D claims and 746 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify DAVID SOLA-DEL VALLE, MD's credentials?
DAVID SOLA-DEL VALLE, MD's NPI is 1235423260 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology